Navigation Links
YERVOY (ipilimumab) approved for the treatment of previously treated advanced melanoma in the EU
Date:7/14/2011

Paris, 14 July 2011 Bristol-Myers Squibb today announced that the European Commission has approved YERVOY (ipilimumab) for the treatment of adult patients with previously-treated advanced melanoma.

YERVOY, an innovative immunotherapy, showed long-term survival in the treatment of patients with advanced melanoma in a randomised, double-blind Phase III study published in the New England Journal of Medicine in June 2010.(1) Based on the survival (Kaplan-Meier) curve, the 1 and 2-year estimated survival rates for patients treated with YERVOY were 46% and 24% respectively vs. 25% and 14% in the comparator arm with some patients alive at 3 and 4 years.

"With the approval of YERVOY physicians now have an important new option to offer to patients with metastatic melanoma. This is a chance of not just months but potentially 3 to 4 years of prolonged survival for some patients in the treatment of metastatic melanoma," comments Professor Alexander Eggermont, General Director, Institut Gustave Roussy, Paris, France. "There is hope that YERVOY's novel mode of action, together with the fact that the recommended complete course of treatment with YERVOY (3 mg/kg) includes 4 infusions over 3 months, could potentially change the way we treat patients with previously treated advanced melanoma. It is an example of what can be done through unleashing the power of one's own immune response."

Bristol-Myers Squibb will now work closely with local health authorities to expedite the availability of YERVOY across the European Union. Prior to approval, the Company provided ipilimumab to nearly 3,000 patients throughout Europe through Compassionate Use / Named Patient Programmes. The Company remains committed to helping ensure that appropriate patients who need YERVOY will receive it while the reimbursement process is finalised by the relevant authorities throughout Europe.

Ron Cooper, President Bristol-Myers Squibb Europe, stated: "With an aver
'/>"/>

Contact: Elzbieta Zawislak
elzbieta.zawislak@bms.com
33-615-523-580
TogoRun
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Rochester technology to enhance eyesight approved by FDA
2. FDA Bans Unapproved Prescription Cough, Cold and Allergy Meds
3. New drug for use in bone scans approved
4. Pradaxa Approved to Fight Dangerous Irregular Heartbeat, Stroke
5. First Patient Treated in U.S.-Approved Embryonic Stem Cell Trial
6. The Good Nite Lite Awarded the Parent Tested Parent Approved Seal
7. U.S. FDA Adds 25 New Firms to Import Alert for Promotion of Unapproved New Drugs According to FDAImports.com, LLC
8. doeLegal and Zapproved Sign Alliance to Add Legal Hold Pro to Suite of Powerful Online Legal Solutions
9. Parent Tested Parent Approved Media Announces their Winning Products for the Summer 2010 Campaign
10. Expert Approved: FatWallet Guides Mother's Day Shoppers to the Best Deals Online
11. Khanna Institute to Offer Newly FDA Approved Expanded Range of Intacs for Keratoconus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... 1, 2014 Patients with increased inflammation, including ... greatly increased risk of depression. For example, a ... hepatitis C virus infection causes depression in approximately ... more commonly known as fish oil, have a ... risk of heart disease and reducing triglyceride levels. ...
(Date:10/1/2014)... Insuranceragents.info has released a new blog ... plan for vulnerable family members. , Life insurance plans ... in the family should always carry a life insurance ... the rest of the family. , Clients can ... more from temporary coverage or from a permanent policy. ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 ... networking and relationship-marketing firm, announced today the ... Executive® and Project of the Year Awards ... makers representing organizations in financial services, commercial, ... large-scale technology endeavors that address key issues ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Between 23 ... in the U.S., according to figures from the National ... Diseases Association (AARDA), and many of them have something ... of having undiagnosed celiac disease. Gluten Free Therapeutics, ... awareness of undiagnosed celiac disease by publishing a series ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Scientists at ... three drugs that target immune system proteins has the ... has just posted details of the new study on ... now. , Researchers in the UWA School of ... anti-CTLA-4 drugs to mice with mesothelioma with promising results. ...
Breaking Medicine News(10 mins):Health News:Omega-3 fatty acids may prevent some forms of depression 2Health News:Life Insurance for Families - Clients Can Compare Affordable Rates Online! 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 3Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 4Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 5Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 6Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 7Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 3Health News:New Mesothelioma Study Says Mice Cured by Immuntherapy “Cocktail”, Reports Surviving Mesothelioma 2
... journal Science that a team of Californian researchers have claimed ... plays an important role in making microscopic worms live longer//. ... equation, the longer you live, the greater your chances of ... is believed that a key element in determining whether a ...
... needs no treatment. Infants aging a few days may get baby ... ,It appears as red or white bumps/spots, from the stage ... infant. // Baby acne typically occurs on the face and chest. ... ointments or creams when it typically appears on face and chest ...
... in the June 2006 issue of the International Journal ... American Society //for Therapeutic Radiology and Oncology, says that ... partial radiation for the breast in order to combat ... ,A seroma is retention of fluid in ...
... up four super speciality hospitals in four zones of the ... covered under its scheme//. ,'These facilities will be ... Mumbai or Pune,' ESI director general Ramesh Inder Singh said ... be totally new ones or existing ESI hospitals would be ...
... latest cookbook by Britain-based celebrity chef Mridula Baljekar, has ... Asian Cuisine Cookbook' category//. ,Baljekar, who runs the ... the award at a star-studded ceremony in Kuala Lumpur, ... ,'I am absolutely overwhelmed and highly honoured ...
... and sexual dysfunction may find Viagra a good option ... express improved sexual enjoyment, orgasm and a less painful ... sexual dysfunction caused by vaginal dryness, and several other ... University of Catania in Italy, have said that the ...
Cached Medicine News:
(Date:10/1/2014)... , Oct. 1, 2014 NeuroCall, Inc., ("NeuroCall") ... for its Telestroke and Teleneurology services. Dr. Ricardo ... commented, "We are extremely proud that our quality of ... we continue to provide lifesaving support and continuity of ... hospitals throughout the United States ." ...
(Date:10/1/2014)... 2014  Varian Medical Systems (NYSE: VAR ... the fourth quarter of fiscal year 2014 following the ... The news release will be followed by a teleconference ... The news release and a link to the conference ... at: www.varian.com/investor .  To access the teleconference call ...
(Date:10/1/2014)... 2014  Express Scripts (NASDAQ: ESRX ) ... Scripts Medicare ® Prescription Drug Plans (PDP) will ... WAG ) (NASDAQ: WAG ), ... support  for their Medicare dollars. Medicare beneficiaries ... or Choice plans for 2015 can ...
Breaking Medicine Technology:NeuroCall Awarded Joint Commission Accreditation 2Varian Medical Systems Schedules Fourth Quarter FY2014 News Release and Conference Call 2Express Scripts Collaborates with Walgreens to Create Value-Driven Medicare Prescription Drug Plan Pharmacy Network 2Express Scripts Collaborates with Walgreens to Create Value-Driven Medicare Prescription Drug Plan Pharmacy Network 3Express Scripts Collaborates with Walgreens to Create Value-Driven Medicare Prescription Drug Plan Pharmacy Network 4
... The U.S. Food and Drug Administration today announced ... Centers of Excellence in Regulatory Science and Innovation (CERSI). ... centers, which will be located at the University of ... and training needed to modernize and improve the ways ...
... Preserve Community Pharmacy Access NOW! (PCPAN) coalition ... Americans from increased costs and decreased access to quality ... Scripts Inc. and Medco Health Solutions Inc., two pharmacy ... on the coalition,s website, outlines the negative impact of ...
Cached Medicine Technology:FDA Invests $2 Million in Partnerships Through Centers of Excellence in Regulatory Science and Innovation 2Nationwide Coalition Issues 'Call To Action' To Stop Express Scripts/Medco Merger 2
Injection Cannula, Angled; 20g (0.90) x 1" (25mm); Tip Extension: 5mm, 30g (0.30); Angled at 45°, 2.5mm from Tip....
...
...
Lacrimal Cannula, Straight, Stepped DownSize: 19g x 1-1/2"....
Medicine Products: